Prestige Consumer Healthcare (PBH) Competitors $80.43 +0.04 (+0.05%) (As of 12:21 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, VTRS, and RPRXShould you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Viatris (VTRS), and Royalty Pharma (RPRX). Prestige Consumer Healthcare vs. Inter Parfums Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Medifast Veru Estée Lauder Companies Viatris Royalty Pharma Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations. Does the MarketBeat Community favor PBH or IPAR? Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.56% of users gave Prestige Consumer Healthcare an outperform vote while only 64.80% of users gave Inter Parfums an outperform vote. CompanyUnderperformOutperformPrestige Consumer HealthcareOutperform Votes48970.56% Underperform Votes20429.44% Inter ParfumsOutperform Votes46264.80% Underperform Votes25135.20% Does the media favor PBH or IPAR? In the previous week, Prestige Consumer Healthcare and Prestige Consumer Healthcare both had 6 articles in the media. Inter Parfums' average media sentiment score of 1.14 beat Prestige Consumer Healthcare's score of 1.14 indicating that Inter Parfums is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inter Parfums 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, PBH or IPAR? Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.11B3.58$209.34M$4.1119.57Inter Parfums$1.42B3.05$152.65M$4.6629.00 Do insiders and institutionals hold more shares of PBH or IPAR? 99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Inter Parfums shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 43.9% of Inter Parfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer PBH or IPAR? Prestige Consumer Healthcare presently has a consensus target price of $85.25, suggesting a potential upside of 5.99%. Inter Parfums has a consensus target price of $159.75, suggesting a potential upside of 18.22%. Given Inter Parfums' stronger consensus rating and higher possible upside, analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Inter Parfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PBH or IPAR a better dividend stock? Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.4%. Inter Parfums pays an annual dividend of $3.00 per share and has a dividend yield of 2.2%. Prestige Consumer Healthcare pays out 46.2% of its earnings in the form of a dividend. Inter Parfums pays out 64.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Prestige Consumer Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio. Is PBH or IPAR more profitable? Prestige Consumer Healthcare has a net margin of 18.54% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare18.54% 12.23% 6.14% Inter Parfums 10.60%16.34%10.82% Which has more risk and volatility, PBH or IPAR? Prestige Consumer Healthcare has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. SummaryInter Parfums beats Prestige Consumer Healthcare on 11 of the 19 factors compared between the two stocks. Ad Jack Carter Trading"X-Ray Vision" could find thousands of hidden market opportunitiesLet me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.Just tap here to join the presentation. Get Prestige Consumer Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBH vs. The Competition Export to ExcelMetricPrestige Consumer HealthcarePharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$3.97B$6.84B$5.13B$19.69BDividend YieldN/A3.06%4.81%3.51%P/E Ratio19.5710.77135.2443.84Price / Sales3.58283.871,174.5317.78Price / Cash16.5356.6540.4821.73Price / Book2.415.384.885.46Net Income$209.34M$151.62M$118.56M$987.88M7 Day Performance-3.73%-4.82%14.97%-2.17%1 Month Performance-1.30%2.04%15.07%0.81%1 Year Performance33.21%16.11%34.31%16.55% Prestige Consumer Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBHPrestige Consumer Healthcare3.8834 of 5 stars$80.43+0.0%$85.25+6.0%+34.2%$3.97B$1.11B19.57540Positive NewsIPARInter Parfums4.0972 of 5 stars$135.39-0.5%$159.75+18.0%-5.5%$4.34B$1.42B29.36530Analyst ForecastShort Interest ↑Positive NewsHLFHerbalife4.6886 of 5 stars$7.24-3.2%$9.90+36.7%-51.9%$729.73M$5.00B8.669,200USNAUSANA Health Sciences2.8185 of 5 stars$36.54-0.3%$35.00-4.2%-30.7%$696.45M$921.01M12.951,800NUSNu Skin Enterprises4.3084 of 5 stars$7.34-2.0%$8.88+20.9%-62.2%$364.88M$1.78B-3.593,700Positive NewsNATRNature's Sunshine Products3.3694 of 5 stars$15.66+0.3%$19.00+21.3%-5.2%$289.33M$445.10M17.55814MEDMedifast1.3306 of 5 stars$18.25-4.7%$17.00-6.8%-72.8%$199.62M$674.48M29.03870VERUVeru2.1403 of 5 stars$0.76+5.0%$4.00+427.1%-6.1%$111.08M$14.09M-1.51189Earnings ReportNews CoverageGap UpELEstée Lauder Companies4.9139 of 5 stars$79.18-1.1%$98.57+24.5%-45.6%$28.42B$15.61B142.9362,000Short Interest ↓Positive NewsVTRSViatris1.4235 of 5 stars$12.64+0.1%$13.67+8.1%+22.6%$15.09B$15.05B-17.0738,000RPRXRoyalty Pharma4.7126 of 5 stars$25.09+1.0%$41.67+66.1%-8.2%$14.78B$2.36B12.8780 Related Companies and Tools Related Companies IPAR Competitors HLF Competitors USNA Competitors NUS Competitors NATR Competitors MED Competitors VERU Competitors EL Competitors VTRS Competitors RPRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:PBH) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBH Stock Alerts